Medical Cannabis Related News
The growth of medical cannabis in Europe
Stephen Murphy, the co-founder and managing director of Prohibition Partners, shares his thoughts on the evolving landscape of medical cannabis in Europe and looks...
Medical benefits of cannabis may be less effective than the liverwort plant
For the first time researchers have found that the substance found in the liverwort plant could have the medical benefits of cannabis, and perhaps...
Health Europa Quarterly Issue 07
Exploring the rapidly changing environment of healthcare, Health Europa Quarterly issue 07 delves into environmental and climate-related harm and discusses the evolution of medical...
It’s time for the UK to rethink its approach to medical cannabis
Producing and exporting the most amount of medical cannabis in the world - why is medical cannabis still being denied to patients in the...
What do you know about the Danish medical cannabis pilot programme?
Minister of Health, Ellen Trane Nørby, provides insight into the recently introduced Danish medical cannabis pilot programme and its implications.
What does the Danish medical...
Can the symptoms of Crohn’s disease be improved by cannabis oil?
Studies show that cannabis oil can significantly improve symptoms of Crohn's disease despite having no effect on gut inflammation.
Being the first of its kind,...
Prescription cannabis in UK: have the law and the drug become best buds?
The UK government has announced that patients can receive prescription cannabis by specialist doctors from 1 November 2018.
Health Europa previously reported upon the review...
The legal medical cannabis movement
Health Europa explores the various approaches to medical cannabis, as more and more countries around the world move in favour of legalisation.
With medical cannabis...
The changing face of medical cannabis in Denmark
Cannabis Danmark CEO Rikke Jakobsen reflects on what the new medical cannabis pilot and development programmes mean for patients, growers and healthcare professionals in...
Tilray gains US Government approval to import a medical cannabis study drug
Import of pharmaceutical grade medical cannabis produced by Tilray® Inc has been approved by the US Drug Enforcement Administration (DEA), with a special study...
Tilray exports 2:100 CBD oil to the United Kingdom
Tilray® Inc., a global leader in cannabis research, production and distribution, announced today that Tilray 2:100, a product produced at Tilray’s federally licensed, Good Manufacturing...
Putting patients first by making cannabinoid medicinal products available
Tilray makes cannabinoid medicinal products available to patients in a time frame that matters and urges others to do the same
Focusing on patients, their...
Cannabis could be used to treat inflammatory bowel diseases
New findings suggest an ingredient in marijuana could mimic the body’s inflammation off-switch, potentially leading to a new drug targeting different types of bowel...
The Canadian Cannabis Act: what does it mean for legalisation elsewhere?
In a history-making political decision, Canada is currently preparing for the legalisation of recreational cannabis, known as the Cannabis Act, which would make it...
Are women being advised to use cannabis to treat morning sickness?
A new study from Denver Health in the US has found that 69% of dispensaries advised a researcher posing as a pregnant woman to...
Health Europa Quarterly Issue 05
Health Europa Quarterly issue 05 outlines the ongoing debate regarding the legalisation of medical cannabis in Europe and the work being done across the...
Survey reveals medical cannabis reduced painkiller use in older adults
A new study has revealed using medical cannabis (or marijuana) substantially reduced chronic pain and dependence on opioid painkillers in 65% of older adults.
Researchers...
Exploring medical cannabis distribution across Europe
The medical benefits of cannabis are well documented, and Tilray is a company that strives to distribute cannabinoid medication to more patients
Tilray is a...
Advancing cannabinoid therapies through research
Canada’s medical cannabis company Tilray defines a medical path for cannabinoid use
Tilray is actively pursuing the daunting goal of delivering innovative, safe and effective...
Legalising medical cannabis – a German perspective
Germany legalised medical cannabis in March 2017; more than a year on, why are some patients still going without? Georg Wurth shares his thoughts.
Medical...